Hepatic stellate cells activate and avoid death under necroptosis stimuli: Hepatic fibrosis during necroptosis

• Published in: Journal of gastroenterology and hepatology 2023-12, Vol.38 (12), p.2206-2214
• Main Authors: Oh, Ju Hee, Saeed, Waqar Khalid, Kim, Hye Young, Lee, Seung Min, Lee, A Hyeon, Park, Gye Ryeol, Yoon, Eileen L, Jun, Dae Won
• Format: Article
• Language: English
• Subjects: Bile ducts; Caspase; Cell death; Fatty liver; Fibrosis; Kinases; Liver diseases; MAP kinase; Necroptosis; Oligomerization; Phosphorylation; Stellate cells
• ISSN: 0815-9319; 1440-1746
• DOI: 10.1111/jgh.16368

Necroptosis is an emerging cell death pathway that allows cells to undergo "cellular suicide" in a caspase-independent manner. We investigated the fate of hepatic stellate cells (HSCs) under necroptotic stimuli. The RNA level of mixed lineage kinase domain-like protein (MLKL) is higher in patients with non-alcoholic fatty liver disease than in healthy controls. Hepatic fibrosis was significantly lower in MLKL-KO bile duct ligation (KO-BDL) mice than in wild-type-BDL mice. Necroptotic stimuli caused the death of HT-29 and U937 cells. However, necroptotic stimuli activate HSCs instead of inducing cell death. MLKL inhibitors attenuated fibrogenic changes in HSCs during necroptosis. Unlike HT-29 and U937 cells, MLKL phosphorylation and oligomerization were not observed during necroptosis in HSCs. RNA sequencing showed that NF-κB signaling-related genes were upregulated in HSCs following necroptotic stimulation. Necroptotic stimuli in HSCs increased the nuclear expression of NF-κB, which decreased after MLKL inhibitor treatment. Induction of necroptosis in HSCs led to autophagosome activation and formation, which were attenuated by MLKL inhibitor treatment. HSCs avoid necroptosis due to the absence of MLKL phosphorylation and oligomerization and are activated through autophagosome and NF-κB pathways.